Learn More
ATCC Pseudomonas aeruginosa; Strain PGO2401
Supplier: ATCC BAA2114
Pseudomonas aeruginosa strain PGO2401 is a drug-resistant bacterium that was collected from a sputum sample of a cystic fibrosis patient during a Phase III clinical trial that tested the effectiveness of aerosolized Tobi (Tobramycin). This strain is whole-genome sequenced and has applications in antimicrobial resistance research and drug development.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.